Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy

Cancer Research

Volumn 63, Issue 2, 2003, Pages 308-311

  Gorski, David H ^a   Mauceri, Helena J ^a   Salloum, Rabih M ^a   Halpern, Arielle ^a   Seetharam, Saraswathy ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CELL PROLIFERATION; CHRONOPHARMACOLOGY; CONTROLLED STUDY; FEMALE; IONIZING RADIATION; LONG TERM CARE; LUNG METASTASIS; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; COMBINED MODALITY THERAPY; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PLASMINOGEN;

EID: 0037439961     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ferrante, K., Winograd, B., and Canetta, R. Promising new developments in cancer chemotherapy. Cancer Chemother. Pharmacol., 43 (Suppl.): S61-S68, 1999.
2. Howell, A., Anderson, E., Blamey, R., Clarke, R. B., Dixon, J. M., Dowsett, M., Johnston, S. R., Miller, W. R., Nicholson, R., and Robertson, J. F. The primary use of endocrine therapies. Recent Results Cancer Res., 152: 227-244, 1998.
3. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
4. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
5. Mauceri, H. J., Seetharam, S., Beckett, M. A., Schumm, L. P., Koons, A., Gupta, V. K., Park, J. O., Manan, A., Lee, J. Y., Montag, A. G., Kufe, D. W., and Weichselbaum, R. R. Angiostatin potentiates cyclophosphamide treatment of metastatic disease. Cancer Chemother. Pharmacol., 50: 412-418, 2002.
6. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
7. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
8. Teicher, B. A., Holden, S. A., Ara, G., Sotomayor, E. A., Huang, Z. D., Chen, Y. N., and Brem, H. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer, 57: 920-925, 1994.
9. Teicher, B. A., Sotomayor, E. A., and Huang, Z. D. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res., 52: 6702-6704, 1992.
10. Gorski, D. H., Mauceri, H. J., Salloum, R. M., Gately, S., Hellman, S., Beckett, M. A., Sukhatme, V. P., Soff, G. A., Kufe, D. W., and Weichselbaum, R. R. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res., 58: 5686-5689, 1998.
11. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., and Weichselbaum, R. R. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res., 59: 3374-3378, 1999.
12. Hanna, N. N., Seetharam, S., Mauceri, H. J., Beckett, M. A., Jaskowiak, N. T., Salloum, R. M., Hari, D., Dhanabal, M., Ramchandran, R., Kalluri, R., Sukhatme, V. P., Kufe, D. W., and Weichselbaum, R. R. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J., 6: 287-293, 2000.
13. Mauceri, H., Hanna, N., Beckett, M., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G., Sukhatme, V. P., Kufe, D., and Weichselbaum, R. R. Combined effects of angiostatin and ionizing radiation in anti-tumour therapy. Nature (Lond.), 394: 287-291, 1998.
14. Gridley, D. S., Loredo, L. N., Slater, J. D., Archambeau, J. O., Bedros, A. A., Andres, M. L., and Slater, J. M. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect. Prev., 22: 20-29, 1998.
15. Maniwa, Y., Okada, M., Ishii, N., and Kiyooka, K. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest, 114: 1668-1675, 1998.
16. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., Volpert, O., Bouck, N., and Soff, G. A. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. USA, 94: 10868-10872, 1997.
17. Mauceri, H. J., Seetharam, S., Beckett, M. A., Lee, J. Y., Gupta, V. K., Gately, S., Stack, M. S., Brown, C. K., Swedberg, K., Kufe, D. W., and Weichselbaum, R. R. Tumor production of angiostatin is enhanced after exposure to TNF-α. Int. J. Cancer, 97: 410-415, 2002.
18. Teicher, B. A., Holden, S. A., Ara, G., Korbut, T., and Menon, K. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma. Cancer Chemother. Pharmacol., 38: 169-177, 1996.
19. Hari, D., Beckett, M. A., Sukhatme, V. P., Dhanabal, M., Nodzenski, E., Lu, H., Mauceri, H. J., Kufe, D. W., and Weichselbaum, R. R. Angiostatin induces mitotic cell death of proliferating endothelial cells. Mol. Cell. Biol. Res. Commun., 3: 277-282, 2000.